AI Stock Analysis - Pfizer (PFE)
Analysis generated February 9, 2026.
Pfizer Inc. (NYSE: PFE) is a well-established pharmaceutical giant, founded in 1849 and headquartered in New York City. The company is primarily known for its wide portfolio of medicines, including vaccines and consumer healthcare products. Pfizer’s recent claim to fame is its COVID-19 vaccine, developed in collaboration with BioNTech. The company operates globally, generating billions in revenue, and is known for its commitment to innovation and substantial investments in R&D.
Stock Alerts - Pfizer (PFE)
 |
Pfizer | April 1 News Alert: Global vaccine passport push accelerates as WHO partners with Singapore firm tied to Pfizer and Bill Gates |
|
Pfizer | March 21 News Alert: Pfizer Recommends Shareholders Reject Tutanota's Mini-Tender Offer To Acquire 1M Pfizer Common Stock At $32/Share |
|
Pfizer | March 17 Reddit mentions are up by 922% in the last 24h. |
|
Pfizer | March 13 Gilbert Cisneros (member of U.S. congress) is buying shares |
Download our app on iOS or Android to get future alerts delivered in real-time.
Alternative Data for Pfizer
About Pfizer
Pfizer Inc is a biopharmaceutical company that discovers, develops, manufactures, and markets healthcare products including medicines, and vaccines as well as many of the consumer healthcare products.
| Price | $27.03 |
| Target Price | Sign up |
| Volume | 33,789,069 |
| Market Cap | $156B |
| Year Range | $22.7 - $28.55 |
| Dividend Yield | 6.35% |
| PE Ratio | 20.2 |
| Analyst Rating | 42% buy |
| Earnings Date | May 5 '26 |
| Industry | Drug Manufacturers |
In the news
 |
Why Pfizer and other blue-chip brands are building internal AI search hubs to reclaim controlApril 9 - Digiday |
$1.05 Bn Biopharmaceutical CXO Markets - Global Forecast Report 2026-2032: How Leading Pharmas Such as Pfizer, Roche, Novartis, Sanofi, and AstraZeneca Navigate the Evolving DynamicsApril 9 - GlobeNewswire |
|
Messenger RNA (mRNA) Market Projected to Reach $20.99 Billion by 2035 - Moderna, Pfizer, and Others Propel mRNA Expansion into New Therapeutic AreasApril 7 - GlobeNewswire |
|
Biotech giant Pfizer abandoning South San Francisco research siteApril 6 - SFGate |
|
Pfizer to close South San Francisco research site by end of AprilApril 6 - SFGate |
|
 |
Why US universities are losing their edge to China: Here’s what Pfizer CEO Albert Bourla saysApril 6 - The Times of India |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q4 '25 | 17.6B | 5.27B | 12.3B | -1.65B | -930M | 0.660 |
| Q3 '25 | 16.7B | 4.17B | 12.5B | 3.54B | 5.65B | 0.870 |
| Q2 '25 | 14.7B | 5.23B | 9.42B | 2.91B | 5.32B | 0.510 |
| Q1 '25 | 13.7B | 3.89B | 9.83B | 2.97B | 5.06B | 0.920 |
| Q4 '24 | 17.8B | 4.8B | 13B | 403M | 5.14B | 0.630 |
Insider Transactions View All
| DAMICO JENNIFER B. filed to sell 11,850 shares at $25.9. March 6 '25 |
| BLAYLOCK RONALD E filed to buy 27,707 shares at $25.7. February 14 '25 |
| Gottlieb Scott filed to buy 10,000 shares at $28.2. October 31 '24 |
| DAMICO JENNIFER B. filed to sell 8,582 shares at $28.7. August 14 '24 |
| Gottlieb Scott filed to buy 9,000 shares at $26.5. December 19 '23 |
Similar companies
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Gilbert Cisneros |
Mar 10, 26 | Buy | $1K - $15K |
| James French Hill |
Jan 26, 26 | Sell | $100K - $250K |
| Gilbert Cisneros |
Jan 13, 26 | Sell | $1K - $15K |
Read more about Pfizer (PFE) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, x followers, x mentions, youtube subscribers, news mentions, customer reviews, lobbying cost, business outlook & linkedin employees.
FAQ - Pfizer
The Market Cap of Pfizer is $156B.
As of today, Pfizer's PE (Price to Earnings) ratio is 20.2.
Pfizer will report its next earnings on May 5 '26.
Currently, the price of one share of Pfizer stock is $27.03.
The PFE stock price chart above provides a comprehensive visual representation of Pfizer's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Pfizer shares. Our platform offers an up-to-date PFE stock price chart, along with technical data analysis and alternative data insights.
Yes, Pfizer (PFE) offers dividends to its shareholders, with a dividend yield of 6.35%. This dividend yield represents Pfizer's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Pfizer in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.
Some of the similar stocks of Pfizer are Johnson & Johnson, Eli Lilly and Company, Astrazeneca, AbbVie, and TherapeuticsMD.
